Surgery and cancer promotion: Are we trading beauty for cancer?

QJM: An International Journal of Medicine

Volumn 104, Issue 9, 2011, Pages 811-815

  Goldstein, M R ^a   Mascitelli, L ^b  

^a Medical Service ^*  (United States)

^b Medical Service   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; CATECHOLAMINE RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLOOXYGENASE 2 INHIBITOR; HALOTHANE; ISOPRENALINE; KETAMINE; MELATONIN; NICOTINE; NORADRENALIN; PROPRANOLOL; PROSTAGLANDIN RECEPTOR; THIOPENTAL; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTHROPLASTY; AUTOPSY; BETA ADRENERGIC RECEPTOR BLOCKING; BLADDER CANCER; BRAIN CANCER; BREAST CANCER; BREAST ENDOPROSTHESIS; BREAST RECONSTRUCTION; CANCER CELL; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CELL ACTIVITY; CELL DEATH; CELL INFILTRATION; CELL PROLIFERATION; CELLULAR IMMUNITY; COLON CANCER; DEPRESSION; ENDOTHELIUM CELL; ENZYME ACTIVATION; FIBROBLAST; FOLLOW UP; GENE EXPRESSION; GENERAL ANESTHESIA; HUMAN; HYPOTHERMIA; HYSTERECTOMY; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSURVEILLANCE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; LEUKEMIA; LOCAL ANESTHESIA; LUNG CANCER; LYMPHOCYTE; MACROPHAGE; MELANOMA; METASTASIS; MICROSCOPY; NATURAL KILLER CELL; NONHUMAN; NOTE; NUTRITIONAL STATUS; OVARY CARCINOMA; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREMENOPAUSE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STOMACH CANCER; SURGICAL STRESS; TONSILLECTOMY; TRANSURETHRAL RESECTION; TUMOR CELL; TUMOR GROWTH; TUMOR PROMOTION; TUMOR XENOGRAFT;

EID: 79960006847     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcr039     Document Type: Note

References (55)

1. Aliperti LA, Predina JD, Vachani A, Singhal S. Local and systemic recurrence is the Achilles heel of cancer surgery. Ann Surg Oncol 2011; 18:603-7.
2. Demicheli R, Retsky MW, Hrushesky WJM, Baum M, Gukas ID. The effects of surgery on tumor growth: a century of investigations. Ann Oncol 2008; 19:1821-8.
3. Retsky MW, Demicheli R, Hrushesky WJM, Baum M, Gukas ID. Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer. APMIS 2008; 116:730-41.
4. Brinton LA, Lubin JH, Burich MC, Colton T, Brown L, Hoover RH. Cancer risk at sites other than the breast following augmentation mammoplasty. Ann Epidemiol 2001; 11:248-256.
5. McLaughlin JK, Nyrén Blot WJ, Yin L, Josefsson S, Fraumeni JF, et al. Cancer risk among women with cosmetic breast implants: a population-based cohort study in Sweden. J Natl Cancer Inst 1998; 90:156-8.
6. Gago-Dominguez M, Castelao JE, Yuan J-M, Ross RK, Yu MC. Increased risk of renal cell carcinoma subsequent to hysterectomy. Cancer Epidemiol Biomarkers Prev 1999; 8:999--1003.
7. Altman D, Yin L, Johansson A, Lundholm C, Grönberg H. Risk of renal cell carcinoma after hysterectomy. Arch Intern Med 2010; 170:2011-16.
8. Brasky TM, Bonner MR, Dorn J, Marhsall JR, Vena JE, Brasure JR, et al. Tonsillectomy and breast cancer risk in the Western New York Diet Study. Cancer Causes Control 2009; 20:369-74.
9. Kang D, Chokkalingam AP, Gridley G, Nyren O, Johansson JE, Adami HO, et al. Benign prostatic hyperplasia and subsequent risk of bladder cancer. Br J Cancer 2007; 96:1475-9.
10. Visuri T, Pulkkinen P, Paavolainen P, Pukkala E. Cancer risk is not increased after conventional hip arthroplasty: a nationwide study from the Finnish Arthroplasty Register with follow-up of 24 636 patients for a mean of 13 years. Acta Orthrop 2010; 81:77-81.
11. Onega T, Baron J, MacKenzie T. Cancer after total joint arthroplasty: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15:1532-7.
12. Fryzek JP, Ye W, Signorello LB, Lipworth L, Blot WJ, McLaughlin JK, et al. Incidence of cancer among patients with knee implants in Sweden, 1980-1994. Cancer 2002; 94:3057-62.
13. Signorello LB, Ye W, Fryzek JP, Lipworth L, Fraumeni JF, Blot WJ, et al. Nationwide study of cancer risk among hip replacement patients in Sweden. J Natl Cancer Inst 2001; 93:1405-10.
14. Hall MJ, DeFrances CJ, Williams SN, Golosinskiy A, Schwartzman A. National hospital discharge survey: 2007 summary. National Health Statistics Reports. The Division of Health Care Statistics, 2010. [http:/www.cdc.gov/nchs/data/nhsr/nhsr029.pdf] Accessed 15 January 2011.
15. Cullen KA, Hall MJ, Golosinskiy A. Ambulatory surgery in the United States, 2006. National Health Statistics Reports. The Division of Health Care Statistics, 2009. [http://www.cdc.gov/nchs/data/nhsr/nhsr011.pdf] Accessed 15 January 2011.
16. American Society of Plastic Surgeons. Report of the 2009 Statistics, 2010; [http://www.plasticsurgery.org/Documents/Media/statistics/2009-US-cosmeticreconstructiveplasticsurgeryminimally-invasive-statistics.pdf] Accessed 15 January 2011.
17. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277-300.
18. Black WC, Welch G. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 1993; 328:1237-43.
19. Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Anderson JA. Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer 1987; 56:814-19.
20. Naumov GN, Folkman J, Straume O, Akslen LA. Tumor-vascular interactions and tumor dormancy. APMIS 2008; 116:569-85.
21. Hüsemann Y, Geigl JB, Schubert F, Musiani P, Meyer M, Burghart E, et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008; 13:58-68.
22. Hölzel D, Eckel R, Emeny RT, Engel J. Distant metastases do not metastasize. Cancer Metastasis Rev 2010; 29:737-50.
23. Meng S, Tripathy D, Frenkel EP, Shete S, Naftalis EZ, Huth JF, et al. Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res 2004; 10:8152-62.
24. Ossowski L, Aguirre-Ghiso JA. Dormancy of metastatic melanoma. Pigment Cell Melanoma Res 2009; 23:41-56.
25. Naumov GN, Folkman J, Straume O. Tumor dormancy due to failure of angiogenesis: role of the microenvironment. Clin Exp Metastasis 2009; 26:51-60.
26. Peeters CFJM, de Waal RMW, Wobbes T, Ruers TJM. Metastatic dormancy imposed by the primary tumor: does it exist in humans? Ann Surg Oncol 2008; 15:3308-15.
27. Kong B, Michalski CW, Friess H, Kleeff. Surgical procedure as an inducer of tumor angiogenesis. Exp Oncol 2010; 32:186-9.
28. Maniwa Y, Okada M, Ishii N, Kiyooka K. Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer. Chest 1998; 114:1668-75.
29. Bogden AE, Moreau J-P, Eden PA. Proliferative response of human and animal tumours to surgical wounding of normal tissues: onset, duration and inhibition. Br J Cancer 1997; 75:1021-7.
30. Sequeira JL, Kobayasi SS, Rodrigues MA. Early and late effects of wound healing on development of colon tumours in a model of colon carcinogenesis by 1,2-dimethylhydrazine in the rat. Pathology 2000; 32:250-2.
31. Belizon A, Balik E, Feingold DL, Bessler M, Arnell TD, Forde KA, et al. Major abdominal surgery increases plasma levels of vascular endothelial growth factor: open more so than minimally invasive methods. Ann Surg 2006; 244:792-8.
32. Indraccolo S, Favaro E, Amadori A. Dormant tumors awaken by a short-term angiogenic burst: the spike hypothesis. Cell Cycle 2006; 5:1751-5.
33. Indraccolo S, Stievano L, Minuzzo S, Tosello V, Esposito G, Piovan E, et al. Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment. Proc Natl Acad Sci USA 2006; 103:4216-21.
34. Lee J-W, Shahzad MMK, Lin YG, Armaiz-Pena G, Mangala LS, Han H-D, et al. Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res 2009; 15:2695-2702.
35. Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res 2010; 70:7042-52.
36. Chakroborty D, Sarkar C, Basu B, Dasgupta PS, Basu S. Catecholamines regulate tumor angiogenesis. Cancer Res 2009; 69:3727-30.
37. Palm D, Lang K, Niggemann B, Drell TL IV, Masur K, Zaenker KS. The norepinephrine-driven metastasis development of PC-3 human prostate cells in BALB/c nude mice is inhibited by β-blockers. Int J Cancer 2006; 118:2744-9.
38. Algazi M, Plu-Bureau G, Flahault A, Dondon MG, Lê MG. Could treatments with β-blockers be associated with a reduction in cancer risk? Rev Epidemiol Sante Publique 2004; 52:53-65.
39. Perron L, Bairati I, Harel F, Meyer F. Antihypertensive drug use and the risk of prostate cancer (Canada). Cancer Causes Control 2004; 15:535-41.
40. Powe DG, Voss MJ, Habashy HO, Zänker KS, Green AR, Ellis IO, et al. β-blocker treatment is associated with a reduction in tumour metastasis and an improvement in specific survival in patients with breast cancer. Abstracts of the 7th European Breast Cancer Conference 2010; Barcelona, Spain. 24-27 March 2010. Abstract 445, p. 188.
41. Goldfarb Y, Ben-Eliyahu S. Surgery as a risk factor for breast cancer recurrence and metastasis: mediating mechanisms and clinical prophylactic approaches. Breast Disease 2006; 26:99-114.
42. Shakhar G, Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients? Ann Surg Oncol 2003; 10:972-92.
43. Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M. The role of the perioperative period in recurrence after cancer surgery. Anesth Analg 2010; 110:1636-43.
44. Cronin AJ, Keifer JC, Davies MF, King TS, Bixler EO. Melatonin secretion after surgery. Lancet 2000; 356:1244-5.
45. Jung B, Ahmad N. Melatonin in cancer management: progress and promise. Cancer Res 2006; 66:9789-93.
46. Cardinali DP, Esquifino AI, Srinivasan V, Pandi-Perumal SR. Melatonin and the immune system in aging. Neuroimmunomodulation 2008; 15:272-8.
47. Thaker PH, Lutgendorf SK, Sood AK. The neuroendocrine impact of chronic stress on cancer. Cell Cycle 2007; 6:430-3.
48. Armaiz-Pena GN, Lutgendorf SK, Cole SW, Sood AK. Neuroendocrine modulation of cancer progression. Brain Behav Immunity 2009; 23:10-15.
49. Wong HP, Yu L, Lam EK, Tai EK, Wu WK, Cho CH. Nicotine promotes colon tumor growth and angiogenesis through β-adrenergic activation. Toxicol Sci 2007; 97:279-87.
50. Davis R, Rizwani W, Banerjee S, Kovacs M, Haura E, Coppola D, et al. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS ONE 2009; 4:e7524.
51. 3 inhibits angiogenesis in vitro and in vivo. Circ Res 2000; 87:214-20.
52. Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: global perspective. Ann Epidemiol 2009; 19:468-83.
53. Grant WB. How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer? An examination using Hill's criteria for causality. Dermato-Endocrinology 2009; 1:17-24.
54. Ginde AA, Liu MC, Camargo CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169:626-32.
55. Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 2010; 121:297-300.